0001213900-26-053415
SEC filingSteakholder Foods Ltd., an Israeli deep-tech company developing 3D-printed alternative protein products, is registering up to $8 million in ADSs for resale by a selling shareholder under an ELOC agreement.
Steakholder Foods Ltd. is an Israeli deep-tech company that has developed 3D-printing technology for producing plant-based meat and seafood analogs. The company is at an early commercial stage, expecting to launch its own branded alternative protein foods in 2026. Its primary offering includes 3D printers and associated ingredient blends. The company has no disclosed revenue from product sales and has accumulated a deficit of $89.9 million as of December 31, 2025. Its auditor has expressed substantial doubt about its ability to continue as a going concern.
The registration statement covers the resale of up to 5,693,950 ADSs (each representing 4,000 ordinary shares) by Alumni Capital LP, the selling shareholder, under an Equity Line of Credit (ELOC) Purchase Agreement. The ELOC allows Steakholder to sell up to $8 million in ADSs to Alumni Capital at a price equal to 94% of the volume-weighted average price over five days. The company will receive proceeds only from sales to the selling shareholder, not from resales. Proceeds are intended for working capital and general corporate purposes.
The offering poses significant dilution risk. The 5,693,950 ADSs represent approximately 373% of the currently outstanding ordinary shares (6,107,500,659 ordinary shares as of May 5, 2026). If all ADSs are issued, total ordinary shares would rise to 28,883,300,659. The ELOC purchase price mechanism, based on a discount to market, could lead to downward pressure on the stock price as the selling shareholder resells shares. Additionally, the company may need to sell more ADSs than registered to receive the full $8 million if prices decline, requiring further registration and dilution.
Key risks include the uncertainty of the amount and timing of funds raised under the ELOC, the potential for substantial dilution, and the company's reliance on external financing to continue operations. The company also faces risks related to its evolving business model, regulatory approvals for novel foods, and geopolitical instability in Israel. Management is led by CEO Arik Kaufman, who has experience in foodtech and venture capital. The board has a classified structure with staggered three-year terms, which may deter takeovers.
Overall, this filing is highly material due to the potential for massive dilution and the company's precarious financial position. Investors should carefully consider the risks before investing.